Chris Gardner net worth
Quick answer
Chris Gardner's estimated net worth is $15.0M (range $10.5M – $22.5M) as of 2026. Chris Gardner is Founder at Sequence Bio. Sequence Bio valuation.
Chris Gardner is Founder at Sequence Bio (YC S19). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Massachusetts Institute of Technology
- Region: Canada
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 52
- Website: https://www.sequencebio.com/
Who is Chris Gardner?
Chris Gardner is a founder at Sequence Bio, which focuses on genetic research and data-driven medicine.
Highlights:
- Massachusetts Institute of Technology
- Dartmouth College
- Notable for contributions to genomics
About Sequence Bio
90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.
FAQ: Chris Gardner net worth and Sequence Bio valuation
What is Chris Gardner's net worth?
Chris Gardner's estimated net worth is $15.0M (range $10.5M – $22.5M) as of 2026. Chris Gardner is Founder at Sequence Bio. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Sequence Bio valuation?
Sequence Bio's estimated valuation on Entrepreneurial Check is $30.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Chris Gardner's role?
Chris Gardner is Founder at Sequence Bio, a Y Combinator-backed startup (batch S19).